📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A randomised, placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer†. (2014)

First Author: McNeish IA

Attributed to: Infrastructure for collaboration: Leeds MRC Medical Bioinformatics Centre funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/annonc/mdu363

PubMed Identifier: 25070546

Publication URI: http://europepmc.org/abstract/MED/25070546

Type: Journal Article/Review

Volume: 25

Parent Publication: Annals of oncology : official journal of the European Society for Medical Oncology

Issue: 10

ISSN: 0923-7534